Clinical trial

Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting Conditions

NCT02006602

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-12-13

PhasePHASE1

Study timeline

Study start (actual)2013-12-13Date precision: day

Registry last updated2018-03-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensionunresolved

Interventions

Candesartan cilexetil (GW615775, Test formulation)DRUG

Candesartan cilexetil (Reference treatment)DRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02006602 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.